Literature DB >> 7680579

Direct effects of 13-cis and all-trans retinoic acid on normal bone marrow (BM) progenitors: comparative study on BM mononuclear cells and on isolated CD34+ BM cells.

D R van Bockstaele1, M Lenjou, H W Snoeck, F Lardon, P Stryckmans, M E Peetermans.   

Abstract

The effects of both 13-cis-and all-trans retinoic acid (RA) on colony formation of normal bone marrow (BM) progenitors were investigated in semi-solid (methylcellulose) assays, using either isolated CD34+ cells or BM mononuclear cells. Single cell liquid cultures were performed to further discriminate between direct and indirect effects. RA action results in significant decrease of colony forming units (CFUs). This effect is more pronounced starting from CD34+ progenitors than starting from total BM. This overall decrease in CFUs is due to selective inhibition of CFU-M (macrophage) and erythroid colonies (BFU-E). At the single cell level the CFU-M inhibition is confirmed with--in addition--a significant inhibition of CFU-GM (granulocyte-macrophage) and a marked stimulation of CFU-G (granulocyte)s. Both retinoids exert the above-mentioned effects. All-trans RA, however, is effective at a tenfold lower concentration (10(-7)M) than 13-cis RA (10(-6)M). Results on CD34+ BM fractions (substantially reduced in accessory cells) demonstrate that the described effects can probably be attributed to the direct action of RA on these progenitors; single progenitor (CD34+) cell liquid cultures further prove this point.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680579     DOI: 10.1007/bf01695885

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  32 in total

1.  The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.

Authors:  H J Bühring; A Ullrich; K Schaudt; C A Müller; F W Busch
Journal:  Leukemia       Date:  1991-10       Impact factor: 11.528

2.  All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.

Authors:  C Chomienne; N Balitrand; P Ballerini; S Castaigne; H de Thé; L Degos
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

3.  Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid.

Authors:  P H Wiernik; J P Dutcher; E Paietta; W N Hittelman; R Vyas; M Strack; S Castaigne; L Degos; R E Gallagher
Journal:  Leukemia       Date:  1991-06       Impact factor: 11.528

4.  cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro.

Authors:  H J Lawrence; K Conner; M A Kelly; M R Haussler; P Wallace; G C Bagby
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

5.  Roles for the heliodynamic hormones, all trans retinoic acid and 1 alpha, 25-dihydroxyvitamin D3, in control of the hematopoietic cell cycle.

Authors:  I Blazsek; M Comisso; C Farabos; J L Misset
Journal:  Biomed Pharmacother       Date:  1991       Impact factor: 6.529

6.  A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients.

Authors:  Z X Chen; Y Q Xue; R Zhang; R F Tao; X M Xia; C Li; W Wang; W Y Zu; X Z Yao; B J Ling
Journal:  Blood       Date:  1991-09-15       Impact factor: 22.113

7.  Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns.

Authors:  A Nagler; I Riklis; Y Kletter; I Tatarsky; I Fabian
Journal:  Exp Hematol       Date:  1986-01       Impact factor: 3.084

8.  1-B-D arabinofuranosyl cytosine and all-trans retinoic acid in combination accelerates and increases monocyte differentiation of myeloid leukemic cells.

Authors:  C Chomienne; N Balitrand; L Degos; J P Abita
Journal:  Leuk Res       Date:  1986       Impact factor: 3.156

9.  Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid.

Authors:  T R Breitman; S J Collins; B R Keene
Journal:  Blood       Date:  1981-06       Impact factor: 22.113

10.  Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17.

Authors:  J Borrow; A D Goddard; D Sheer; E Solomon
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

View more
  5 in total

1.  All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

Authors:  Noweeda Mirza; Mayer Fishman; Ingo Fricke; Mary Dunn; Anthony M Neuger; Timothy J Frost; Richard M Lush; Scott Antonia; Dmitry I Gabrilovich
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

2.  The human placenta is a hematopoietic organ during the embryonic and fetal periods of development.

Authors:  Alicia Bárcena; Mirhan Kapidzic; Marcus O Muench; Matthew Gormley; Marvin A Scott; Jingly F Weier; Christy Ferlatte; Susan J Fisher
Journal:  Dev Biol       Date:  2008-12-03       Impact factor: 3.582

Review 3.  Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.

Authors:  J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

4.  Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages.

Authors:  S Kumar; M P Torres; S Kaur; S Rachagani; S Joshi; S L Johansson; N Momi; M J Baine; C E Gilling; L M Smith; T A Wyatt; M Jain; S S Joshi; S K Batra
Journal:  Oncogene       Date:  2014-06-09       Impact factor: 9.867

5.  Roles of retinoids and retinoic Acid receptors in the regulation of hematopoietic stem cell self-renewal and differentiation.

Authors:  Louise E Purton
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.